cache/5370d12712f6b29c5ca353b07a20058584584fa4a6065c9a6696a647015b4108

COM:EMALEXBIOSCIENCES

Emalex Biosciences, LLC

  • Privately Held

Emalex Biosciences is a biopharmaceutical company dedicated to developing new treatments for rare and orphan neurological conditions. Their first development candidate, Ecopipam, is a novel compound studied as a potential treatment for central nervous system (CNS) disorders, including pediatric Tourette Syndrome.

investor of